Diagnostic options · UAE

Single Gene tests in Dubai & UAE

Compare available Single Gene tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

332

Listed price range

2,000.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene test prices

Showing 316–330 of 332 matching tests.

Single Gene diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2364 TWIST1 Gene Saethre-Chotzen Syndrome Genetic Test This test evaluates the TWIST1 gene for pathogenic variants associated with Saethre-Chotzen syndrome.	Peripheral Whole Blood (EDTA)	21–28 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TWIST1 gene sequence", "TWIST1 gene copy number variations (deletions/duplications)"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9%"}] Preparation ["No specific fasting required", "No medication or diet changes needed"] Indications ["Diagnosis of Saethre-Chotzen syndrome", "Prenatal diagnosis (if parental mutation identified)", "Family screening for at-risk members"] Measurement technique Confirm with laboratory Codes LOINC: 81264-7 ICD-10: Q87.0, Q75.0 Clinical summary This test evaluates the TWIST1 gene for pathogenic variants associated with Saethre-Chotzen syndrome.
TEST-2370 TWIST1 Gene Sequencing for Robinow‑Sorauf Syndrome (NGS) Test This test analyzes the TWIST1 gene to detect mutations associated with Robinow‑Sorauf syndrome, a rare autosomal dominant disorder.	Whole blood (3–5 mL in EDTA tube), or extracted DNA (5 µg minimum)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TWIST1 gene sequence", "Single nucleotide variants", "Small insertions/deletions", "Copy number alterations"] Parameters [] Preparation ["Mandatory pre-test genetic counselling session"] Indications ["Suspected Robinow‑Sorauf syndrome", "Confirmation of diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81307-2 ICD-10: Q87.0 Clinical summary This test analyzes the TWIST1 gene to detect mutations associated with Robinow‑Sorauf syndrome, a rare autosomal dominant disorder.
TEST-5771 TYK2 Gene Tyrosine Kinase 2 Deficiency Genetic Test This genetic test identifies pathogenic variants in the TYK2 gene associated with primary immunodeficiencies like autosomal recessive hyper-IgE syndrome.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TYK2 gene", "Deletion/duplication analysis of the TYK2 gene"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory", "Document all current medications"] Indications ["Suspected autosomal recessive hyper-IgE syndrome", "Evaluation of primary immunodeficiency", "Family history of TYK2-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 101246-5 ICD-10: D82.4 Clinical summary This genetic test identifies pathogenic variants in the TYK2 gene associated with primary immunodeficiencies like autosomal recessive hyper-IgE syndrome.
TEST-3905 UGT1A1 Gene Crigler-Najjar Syndrome Type 2 Genetic Test This genetic test identifies pathogenic variants in the UGT1A1 gene associated with Crigler-Najjar syndrome type 2.	Whole Blood, Extracted DNA, FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["UGT1A1 gene sequence", "Pathogenic variants"] Parameters [] Preparation ["No fasting or dietary preparation required"] Indications ["Diagnostic confirmation of Crigler-Najjar syndrome type 2", "Carrier screening", "Pharmacogenomic guidance"] Measurement technique Confirm with laboratory Codes LOINC: 81289-2 ICD-10: E80.5, Z13.228, Z31.5 Clinical summary This genetic test identifies pathogenic variants in the UGT1A1 gene associated with Crigler-Najjar syndrome type 2.
TEST-2537 UQCC2 Single-Gene NGS Test for Mitochondrial Complex III Deficiency, Nuclear Type 7 This test identifies pathogenic variants in the UQCC2 gene, confirming the diagnosis of nuclear type 7 mitochondrial complex III deficiency.	Peripheral whole blood or FTA card blood spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the UQCC2 gene"] Parameters [] Preparation ["No fasting required", "Inform of any anticoagulant therapy"] Indications ["Suspected UQCC2-related mitochondrial complex III deficiency", "Family history of mitochondrial disease", "Need for accurate genetic counseling and family planning"] Measurement technique Confirm with laboratory Codes LOINC: 96409-4 ICD-10: E88.89 Clinical summary This test identifies pathogenic variants in the UQCC2 gene, confirming the diagnosis of nuclear type 7 mitochondrial complex III deficiency.
TEST-5056 UQCRB Gene Test This test evaluates the UQCRB gene for pathogenic variants associated with mitochondrial complex III deficiency.	Peripheral Whole Blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["UQCRB gene pathogenic variants", "Mitochondrial complex III function"] Parameters [] Preparation [] Indications ["Clinical suspicion for mitochondrial complex III deficiency", "Neurological evaluation"] Measurement technique Confirm with laboratory Codes LOINC: 72296-1 ICD-10: E88.49 Clinical summary This test evaluates the UQCRB gene for pathogenic variants associated with mitochondrial complex III deficiency.
TEST-5161 UQCRC2 Gene Mitochondrial Complex III Deficiency Genetic Test This test identifies pathogenic variants within the UQCRC2 gene, which are associated with mitochondrial complex III deficiency, a rare neurometabolic disorder.	Peripheral whole blood (3–5 mL in EDTA tube), or extracted genomic DNA, or FTA card spot.	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the UQCRC2 gene", "Point mutations", "Indels", "Copy-number variants"] Parameters [] Preparation [] Indications ["Suspected mitochondrial complex III deficiency", "Family screening for UQCRC2 mutations"] Measurement technique Confirm with laboratory Codes LOINC: 92653-0 ICD-10: E88.49 Clinical summary This test identifies pathogenic variants within the UQCRC2 gene, which are associated with mitochondrial complex III deficiency, a rare neurometabolic disorder.
TEST-5941 UROC1 Gene Urocanase Deficiency Genetic Test This genetic test detects pathogenic variants in the UROC1 gene associated with urocanase deficiency.	Whole blood (3-5 ml in EDTA tube) or extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the UROC1 gene", "Copy Number Variations (CNV) in the UROC1 gene"] Parameters [] Preparation [] Indications ["Suspected urocanase deficiency", "Family history of UROC1-related disorders", "Unexplained neurological symptoms"] Measurement technique Confirm with laboratory Codes LOINC: 89278-4 ICD-10: E72.8 Clinical summary This genetic test detects pathogenic variants in the UROC1 gene associated with urocanase deficiency.
TEST-5972 VEGFA Gene Genetic Test for Microvascular Complications of Diabetes Type 1 This test evaluates pathogenic variants in the VEGFA gene associated with increased risk for microvascular complications in type 1 diabetes.	Whole blood (EDTA tube), extracted DNA, or FTA card spot	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["VEGFA gene pathogenic variants", "Risk for diabetic retinopathy", "Risk for diabetic nephropathy", "Risk for diabetic neuropathy"] Parameters [] Preparation [] Indications ["Type 1 diabetes", "Risk assessment for microvascular complications"] Measurement technique Confirm with laboratory Codes LOINC: 81256-6 ICD-10: E10.40 Clinical summary This test evaluates pathogenic variants in the VEGFA gene associated with increased risk for microvascular complications in type 1 diabetes.
TEST-4762 VPS45 Gene Severe Congenital Neutropenia Type 5 (Autosomal Recessive) Genetic Test This test identifies pathogenic variants in the VPS45 gene associated with severe congenital neutropenia type 5.	Whole blood (EDTA), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["VPS45 gene variants", "Pathogenic mutations"] Parameters [] Preparation ["Detailed clinical history focusing on recurrent infections, oral/genital ulcers, neutrophil counts, and family pedigree is mandatory.", "Avoid discontinuing any current treatments; always consult the ordering physician.", "Samples collected on FTA cards must be dried completely before shipment."] Indications ["Clinical suspicion of severe congenital neutropenia type 5", "Family history of autosomal recessive neutropenia", "Genetic counseling of at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 21637-6 ICD-10: D70.0 Clinical summary This test identifies pathogenic variants in the VPS45 gene associated with severe congenital neutropenia type 5.
TEST-2316 WDR19 Gene Sequencing (Short-Rib Thoracic Dysplasia Type 5) Genetic Test This test analyzes the WDR19 gene for mutations associated with short-rib thoracic dysplasia type 5 (SRTD5). It uses next-generation sequencing (NGS) to detect variants in coding e...	Peripheral Whole Blood (EDTA) or Buccal Swab	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["WDR19 gene coding exons", "WDR19 gene splice sites"] Parameters [] Preparation ["No special preparation required for the child"] Indications ["Clinical features of skeletal ciliopathy", "Suspicion of short-rib thoracic dysplasia type 5"] Measurement technique Confirm with laboratory Codes LOINC: 95308-5 ICD-10: Q77.2 Clinical summary This test analyzes the WDR19 gene for mutations associated with short-rib thoracic dysplasia type 5 (SRTD5). It uses next-generation sequencing (NGS) to detect variants in coding exons and splice sites.
TEST-2825 WDR73 Gene Galloway-Mowat Syndrome Genetic Test This test analyzes the WDR73 gene for pathogenic variants associated with Galloway-Mowat syndrome.	Whole blood (peripheral), FTA card, or extracted genomic DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["WDR73 gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No fasting required", "Continue prescribed medications"] Indications ["Diagnosis of Galloway-Mowat syndrome", "Family planning", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 101426-0 ICD-10: Q87.8, Z13.71, Z14.8 Clinical summary This test analyzes the WDR73 gene for pathogenic variants associated with Galloway-Mowat syndrome.
TEST-2327 WNT4 Gene SERKAL Syndrome Genetic Test This test evaluates the WNT4 gene for variants associated with SERKAL syndrome, characterized by sex reversal, renal agenesis, and adrenal hypoplasia.	Whole Blood (Peripheral) or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic and likely pathogenic variants in the WNT4 gene", "Copy number variations (CNVs) within the WNT4 gene"] Parameters [] Preparation [] Indications ["Suspected diagnosis of SERKAL syndrome", "Family history of SERKAL syndrome", "Reproductive risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 79500-5 ICD-10: Q87.8 Clinical summary This test evaluates the WNT4 gene for variants associated with SERKAL syndrome, characterized by sex reversal, renal agenesis, and adrenal hypoplasia.
TEST-2391 WNT5A Gene (Robinow Syndrome, Autosomal Dominant Type 1) Genetic Test This test evaluates the WNT5A gene for pathogenic variants associated with autosomal dominant Robinow syndrome.	Whole Blood (EDTA) – 5 mL	3–4 Weeks (expedited options available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the WNT5A gene coding region", "Canonical splice sites"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": ">99.9% for coding exons and canonical splice sites"}, {"name": "Analytical Sensitivity", "reference_range": ">99.9%"}, {"name": "Precision (SNVs, indels)", "reference_range": "99.9% detection"}] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions or transplants"] Indications ["Suspected diagnosis of autosomal dominant Robinow syndrome", "Genetic counseling for families with a history of Robinow syndrome", "Prenatal diagnosis in high-risk pregnancies"] Measurement technique Confirm with laboratory Codes LOINC: 52050-5 ICD-10: Q87.8 Clinical summary This test evaluates the WNT5A gene for pathogenic variants associated with autosomal dominant Robinow syndrome.
TEST-3041 XPR1 Gene Sequencing Test This diagnostic test evaluates the XPR1 gene for variants associated with idiopathic basal ganglia calcification type 6.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic and likely pathogenic variants in the XPR1 gene", "Single Nucleotide Variants (SNVs)", "Insertions and Deletions (indels)"] Parameters [] Preparation ["Fasting is not required", "Continue all prescribed medications unless advised otherwise by your physician"] Indications ["Diagnosis of idiopathic basal ganglia calcification type 6", "Familial cascade screening for XPR1-related disorders", "Clinical management guidance for neurologists and geneticists"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: G23.8, Z13.79, Z14.8 Clinical summary This diagnostic test evaluates the XPR1 gene for variants associated with idiopathic basal ganglia calcification type 6.

Category overview

Single Gene: overview

When clinical symptoms or family history point directly toward a specific inherited condition, highly focused genetic testing provides the exact, rapid insights necessary for peace of mind. Integrated into our advanced Molecular Genetics services, Single Gene testing meticulously analyzes one specific gene for known disease-causing mutations. Utilizing cutting-edge diagnostic technology, this highly focused molecular screening helps confirm or rule out precise genetic traits, safely guiding targeted medical interventions and family planning strategies. Recognized for specialized diagnostic excellence among diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical precision, and incredibly efficient turnaround times. Take an informed step forward in your health journey—schedule your single gene testing in UAE, book a secure home sample collection, or reach out to our expert medical professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.